NCT04865549View on ClinicalTrials.gov

Sentinel Node After Neoadjuvancy In Node-Positive Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

September 1, 2020

Study Completion Date

January 1, 2021

Conditions
Breast Cancer
Interventions
PROCEDURE

SNB + TAD + Lymphadenectomy

Sentinel Node Biopsy + Targetted Axillary Dissection (Previously to surgery marked cN1 node) + Lymphadenectomy

Trial Locations (1)

08036

Hospital Clínic de Barcelona, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT04865549 - Sentinel Node After Neoadjuvancy In Node-Positive Breast Cancer | Biotech Hunter | Biotech Hunter